FDA Blocks Potentially Dangerous Hypertension Treatment from Market
From Ring of Fire:
Over the weekend, a group of physicians came forward and reported that a potential treatment for high blood pressure had failed clinical testing and would not be allowed on the market.
“It is important that the FDA has the opportunity to review – completely – clinical trial information,” commented Megan McBride, an attorney with the Levin, Papantonio law firm who practices in the areas of personal injury and bad drug litigation. “This treatment was previously heralded but, after additional and thorough analysis, it has now been found to be useless.”
Renal denervation was the subject of the study. It was a surgical procedure for individuals suffering from high blood pressure that could not be successfully controlled or lowered by medication. The procedure involved the insertion of a tube into the renal arteries and then charging them with radio-frequency energy to kill the local nerve endings.
You can read the full article here at Ring of Fire.
= new reply since forum marked as read